Trial intelligence / Profile preview

Podofilox Gel 0.5% vs Condylox in External Anogenital Warts

NCT03532776Phase 3Completed

Sponsor
Dermax
Start
Apr 2018
Primary completion
Dec 2018
Countries
3
01

Overview

A Phase 3 trial of podofilox gel in anogenital warts, sponsored by Dermax. Started Apr 2018; status: completed.

02

Drugs

podofilox gel
03

Conditions

anogenital warts

Beyond the preview

Go deeper on NCT03532776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03532776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call